Specific association of increased vascular endothelial growth factor expression and its receptors with macrophage differentiation of HL-60 leukemia cells

Biochemical and Biophysical Research Communications

Volumn 368, Issue 3, 2008, Pages 543-549

  Ohsaka, Akimichi ^a   Hirota Komatsu, Satoko ^a   Shibata, Miki ^a   Ezaki, Junji ^a   Shinohara, Fumikazu ^b   Yoshida, Tetsuo ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

HL 60; Macrophage differentiation; Tumor angiogenesis; VEGF receptors; VEGF C

Indexed keywords

DIMETHYL SULFOXIDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NEUROPILIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL LYSATE; CELL STRAIN HL 60; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LEUKEMIA CELL; MACROPHAGE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

CELL DIFFERENTIATION; HL-60 CELLS; HUMANS; MACROPHAGES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 39749163348     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.129     Document Type: Article

References (24)

1. Ferrara N., Gerber H.-P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
2. Hicklin D.J., and Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23 (2005) 1011-1027
3. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
4. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., and Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362 (1993) 841-844
5. Strawn L.M., McMahon G., App H., Schreck R., Kuchler W.R., Longhi M.P., Hui T.H., Tang C., Levitzki A., Gazit A., Chen I., Keri G., Orfi L., Risau W., Flamme I., Ullrich A., Hirth K.P., and Shawver L.K. Flk-1 as a target for tumor growth inhibition. Cancer Res. 56 (1996) 3540-3545
6. Masood R., Cai J., Zheng T., Smith D.L., Hinton D.R., and Gill P.S. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98 (2001) 1904-1913
7. Jussila L., and Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol. Rev. 82 (2002) 673-700
8. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4 (2004) 71-78
9. Murdoch C., Giannoudis A., and Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104 (2004) 2224-2234
10. Bingle L., Brown N.J., and Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196 (2002) 254-265
11. Ohsaka A., Takagi S., Takeda A., Katsura Y., Takahashi K., and Matsuoka T. Basic fibroblast growth factor up-regulates the surface expression of complement receptors on human monocytes. Inflamm. Res. 50 (2001) 270-274
12. Joukov V., Sorsa T., Kumar V., Jeltsch M., Claesson-Welsh L., Cao Y., Saksela O., Kalkkinen N., and Alitalo K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16 (1997) 3898-3911
13. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H., Betsholtz C., and Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5 (2004) 74-80
14. Mäkinen T., Veikkola T., Mustjoki S., Karpanen T., Catimel B., Nice E.C., Wise L., Mercer A., Kowalski H., Kerjaschki D., Stacker S.A., Achen M.G., and Alitalo K. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20 (2001) 4762-4773
15. He Y., Karpanen T., and Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim. Biophys. Acta 1654 (2004) 3-12
16. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., and Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7 (2001) 192-198
17. Karpanen T., Egeblad M., Karkkainen M.J., Kubo H., Ylä-Herttuala S., Jäättelä M., and Alitalo K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61 (2001) 1786-1790
18. He Y., Kozaki K., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., and Alitalo K. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 94 (2002) 819-825
19. Skobe M., Hamberg L.M., Hawighorst T., Schirner M., Wolf G.L., Alitalo K., and Detmar M. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159 (2001) 893-903
20. Schoppmann S.F., Birner P., Stöckl J., Kalt R., Ullrich R., Caucig C., Kriehuber E., Nagy K., Alitalo K., and Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161 (2002) 947-956
21. Neufeld G., Cohen T., Shraga N., Lange T., Kessler O., and Herzog Y. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med. 12 (2002) 13-19
22. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 (1998) 735-745
23. Miao H.Q., Lee P., Lin H., Soker S., and Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 14 (2000) 2532-2539
24. Miao H.Q., Soker S., Feiner L., Alonso J.L., Raper J.A., and Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146 (1999) 233-242